Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Eli Lilly press release: ATTAIN-MAINTAIN Phase 3 results
Abrupt cessation can lead to rebound appetite and other effects that proper tapering can minimize
Planning Treatment Breaks Before Conception Most reproductive endocrinologists recommend stopping GLP-1 therapy at least one to three months before attempting pregnancy to allow medication clearance and restoration of normal appetite and glucose regulation
What Not to Take With Retatrutide: Interactions, Foods & Safety Retatrutide is an investigational triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors, currently in clinical trials for obesity and type 2 diabetes
US$ 20.03
US$ 25.90
US$ 29.67
US$ 28.02
